Orthopedic Center: Invest or Not to Invest in a Robotic System and Impacts to the Patient-Physician Relationship
Orthopedic Center: Invest or not to Invest in a Robotic System and
Impacts to the Patient-Physician Relationship
Karissa Keller
Colorado Technical University
Economics in Healthcare HSS 310
Professor Cynthia Bracy
June 24, 2013
In today’s time of demand and supply of healthcare needs, organizations must discover or improve services that can meet the needs of patients’ whole at the same time generating revenue as well as achieving high standards for quality of care. One way organizations have done this is by investing in robotic systems to carry out a range of surgeries. In the following presentation I will discuss the topics of: Investing in the MAKO RIO Robotic System, The Utilization of the RIO Robotic System, Stakeholders of an Orthopedic Surgery, Impact to the Stakeholders, Internal and External Factors that Impact the Purchasing of the MAKO RIO Robotic System, Reaction of the Patients About the RIO Robotic System, and the Impact to the Orthopedic Center’s Competitiveness.
Investing in the MAKO RIO Robotic Arm System Investing in a MAKO RIO Robotic System can become a very beneficial and profitable tool that can propel the center towards reaching our ultimate goals of revenue as well as patient quality of care. The MAKO RIO Robotic system is the “first FDA-cleared robotic arm system for orthopedic surgery,” (MedGadget, 2009). The RIO system consists of a robotic arm that is equipped with intelligent surgical instruments that enables a high level of precision to be achieved as well as high accuracy. The RIO Robotic Arm is available to patients that suffer from Osteoarthritis in the knee and/or hip. Before the RIO Robotic Arm, only medial resurface was possible, but with the RIO medial, patellofemoral, or both components of the bones can be resurfaced (MedGadget, 2009). This innovated robotic system now opens the door for more patients that need total hip and/or knee replacement. The cost of the RIO Robotic system does come with a heavy price tag
Impacts to the Patient-Physician Relationship
Karissa Keller
Colorado Technical University
Economics in Healthcare HSS 310
Professor Cynthia Bracy
June 24, 2013
In today’s time of demand and supply of healthcare needs, organizations must discover or improve services that can meet the needs of patients’ whole at the same time generating revenue as well as achieving high standards for quality of care. One way organizations have done this is by investing in robotic systems to carry out a range of surgeries. In the following presentation I will discuss the topics of: Investing in the MAKO RIO Robotic System, The Utilization of the RIO Robotic System, Stakeholders of an Orthopedic Surgery, Impact to the Stakeholders, Internal and External Factors that Impact the Purchasing of the MAKO RIO Robotic System, Reaction of the Patients About the RIO Robotic System, and the Impact to the Orthopedic Center’s Competitiveness.
Investing in the MAKO RIO Robotic Arm System Investing in a MAKO RIO Robotic System can become a very beneficial and profitable tool that can propel the center towards reaching our ultimate goals of revenue as well as patient quality of care. The MAKO RIO Robotic system is the “first FDA-cleared robotic arm system for orthopedic surgery,” (MedGadget, 2009). The RIO system consists of a robotic arm that is equipped with intelligent surgical instruments that enables a high level of precision to be achieved as well as high accuracy. The RIO Robotic Arm is available to patients that suffer from Osteoarthritis in the knee and/or hip. Before the RIO Robotic Arm, only medial resurface was possible, but with the RIO medial, patellofemoral, or both components of the bones can be resurfaced (MedGadget, 2009). This innovated robotic system now opens the door for more patients that need total hip and/or knee replacement. The cost of the RIO Robotic system does come with a heavy price tag
References: American Medical Association. (2012). Prepare that Claim. Retrieved from American Medical Association: http://www.ama-assn.org/resources/doc/psa/prepare-that-claim.pdf Ananeh-Firempong, O., & Betancourt, J Beth A. Lown MD, J. L. (2008, August 20). Mutual influence in shared decision making: a collaborative study of patients and physicians. Cambridge, MA, USA. Cleary, P., Davis, N., Green, D., Kao, A., & Koplan, J. (1998). Patients ' Trust in Their Physicians Effects of Choice, Continuity, and Payment Method. Journal of General Internal Medicine, 681-686. Emanuel, E., & Lee, E. (2013). Shared Decision Making to Improve Care and Reduce Costs. The New England Journal of Medicine, 6-8. Emord, J. (2013). OBAMACARE 'S IMPACT ON MEDICARE, MEDICAID AND DEBT. Retrieved from NewsWithViews.com: http://www.newswithviews.com/Emord/jonathan290.htm Feldstein, P MAKO Surgical Corp. (2009, December). MAKOplasty Financial Summary. Fort Lauderdale, Florida, United States. MAKO Surigical . (2012). MAKOplasty Center of Excellence Marketing Program. Retrieved from MAKO Surigical Corporation: http://www.makosurgical.com/assets/files/pdfs/COE%20Marketing%20brochure_single%20pgs_205481r01.pdf MAKO Surigical Corp Feldstein, P. (2012). Health Care Economics Seventh Edition. Clifton Park, New York, USA. MAKO Surgical Corp. (2009, December). MAKOplasty Financial Summary. Fort Lauderdale, Florida, United States. MAKO Surigical . (2012). MAKOplasty Center of Excellence Marketing Program. Retrieved from MAKO Surigical Corporation: http://www.makosurgical.com/assets/files/pdfs/COE%20Marketing%20brochure_single%20pgs_205481r01.pdf MAKO Surigical Corp Susan Goold, M. L. (1999 ). The Doctor–Patient Relationship: Challenges, Opportunities, and Strategies. Retrieved from Society of General Internal Medicine: http://www.ncbi.nlm.nih.gov/pmc/articles/PMC1496871/ Thiedke, C